TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: 3.00E+3nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetAlpha-2A adrenergic receptor(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: 3.00E+3nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M4(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: 5.00E+3nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M5(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 8(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 1(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 1(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 4(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 5(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 5(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 6(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M1(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1A(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1A(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M5(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 2nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: <120nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 200nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 300nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 620nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 700nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.16E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.20E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.79E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 2.04E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 2.98E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 3.60E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 5.29E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 7.16E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 7.32E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 7.69E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 7.93E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride intracellular channel protein 1(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 9.00E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 9.86E+3nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.26E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.37E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.39E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.58E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.79E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 2.21E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 2.35E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 2.47E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 3.34E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 3.57E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 3.79E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: >4.20E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 4.24E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 4.88E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair